Next Generation Antimicrobial Platform Focused on Wound Healing, Disinfecting and Decontamination

Patented Veriox^® Technology platform is a single-stop antimicrobial/antitoxin

The Problem

Antimicrobial Resistance (AMR) Pathogens is a Global Healthcare Crisis

Currently, antimicrobials are used to prevent and treat infections. AMR occurs when these medicines no longer work, making infections difficult to treat, resulting in increased risk of disease and death. Today, AMR causes 1+ million deaths annually, and AMR deaths are projected to grow by 70% to 39M+ by 2050.

Armis Biopharma’s Veriox^® technology platform targets these AMR pathogens.

Our Products

Our Mission

Our mission is to decrease the quantity and severity of infections that cause human suffering and death, through the creation and development of novel, targeted, antimicrobial therapies

About Us

Armis Biopharma® Technology

Armis Biopharma’s Veriox^®, a proprietary peracid/hydrogen peroxide based non-systemic antimicrobial agent, is a potent single-stop antimicrobial / anti-toxin platform.

The highly selective action of Peracid – Hydrogen Peroxide has been independently verified by government and private laboratories to eliminate a huge number of bacterial, viral, fungal and toxic agent threats present in today’s environment.

Veriox® features a novel mechanism of action that reduces the likelihood of contributing to resistance against Gram+, Gram-, viral, fungal pathogens and destroys chemical/biological warfare agents.